Skip to content
Washington University School of Medicine in St. Louis

Hospital Medicine Virtual Journal Club

Menu
  • About
  • Archives
  • FAQs
  • How to Access Full-text Articles
  • How to Use
  • Privacy Policy and Terms of Use

Category: lancet haematol

Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study.

lancet haematol • April 30, 2018

Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.

lancet haematol • October 11, 2017

Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.

lancet haematol • April 16, 2017

Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.

lancet haematol • February 22, 2017

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.

lancet haematol • August 30, 2016

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.

lancet haematol • August 2, 2016

Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis.

lancet haematol • January 15, 2016

Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.

lancet haematol • January 15, 2016

Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.

lancet haematol • December 22, 2015

Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.

lancet haematol • December 22, 2015

Follow Us!

Follow Us on FacebookFollow Us on TwitterFollow Us on Instagram

Journal Club via Email

The HMVJC Minute Podcast

Subscribe Now!
  • AnchorAnchor
  • Apple PodcastsApple Podcasts
  • BreakerBreaker
  • Google PodcastsGoogle Podcasts
  • iHeartRadioiHeartRadio
  • PocketCastsPocketCasts
  • PodbayPodbay
  • Radio PublicRadio Public
  • SpotifySpotify
  • TikTokTikTok
  • YouTubeYouTube

Recent Comments

  • Anonymous on Things We Do for No Reason™: Obtaining Urine Testing in Older Adults With Delirium Without Signs or Symptoms of Urinary Tract Infection
  • agario unblocked on Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
  • Ronald M. Chavin on What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak
  • An Examination of Ivermectin and Other Promising Medications in the Prevention and Treatment of COVID | Compounding Corner Pharmacy, Inc. on Montelukast in Hospitalized Patients Diagnosed with COVID-19
  • Nathan Martin on Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial

The HMVJC COVID Reading List

  • Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
  • Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
  • Elevated D-dimer and Adverse In-hospital Outcomes in COVID-19 Patients and Synergism with Hyperglycemia
  • Occurrence and outcomes of possible superadded infections in older adults with COVID-19-cohort study
  • Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: A randomized clinical trial
  • Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
  • Re-examining the widespread policy of stopping SGLT2 inhibitors during acute illness: A perspective based on the updated evidence
  • Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study
  • Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized with COVID-19: A Blinded Randomized Placebo-Controlled Trial
  • Ivermectin for preventing and treating COVID-19

Links

  • WU School of Medicine
  • Dept. of Medicine
  • Division of Hospital Medicine
  • Becker Medical Library
  • Society of Hospital Medicine
  • Today's Hospitalist

Editor: Robert J. Mahoney, M.D., CCS-P, SFHM

Powered by
PubMed

©2022 Washington University in St. Louis